Literature DB >> 10385183

Comparison of Tc-99m sestamibi and Tl-201 gated perfusion SPECT.

E G DePuey1, S Parmett, M Ghesani, A Rozanski, K Nichols, H Salensky.   

Abstract

BACKGROUND: To determine the interpretability of gated thallium-201 perfusion SPECT compared with that performed by use of technetium-99m sestamibi (MIBI), 33 patients with prior myocardial infarction were studied. Patients received 22 to 30 mCi (814 to 1110 MBq) MIBI at peak stress, and a 15-minute gated SPECT acquisition was begun 30 to 40 minutes thereafter. On a subsequent day gated Tl-201 SPECT was acquired for 15 minutes, 4 hours after a resting 3.5 mCi (130 MBq) injection. SPECT was performed over a 180-degree arc by use of a 90-degree angled 2-detector camera.
RESULTS: Gated studies were interpreted independently by 4 experienced physicians. Study quality was graded (0 = uninterpretable to 4 = excellent). Wall motion (0 = normal to 2 = akinetic/dyskinetic) and wall thickening (0 = normal to 2 = absent) were graded for each of 10 segments viewed in orthogonal planes. Left ventricular ejection fraction (LVEF) was calculated by use of software thus far validated only for MIBI. The average count density of mid-ventricular end-diastolic short axis tomograms with sestamibi was 3.47 times greater than with thallium. Mean study quality was 3.4 for MIBI and 1.8 for thallium (P < 10(-6)). No gated MIBI SPECTs, but 2 gated thallium studies (6%) were judged uninterpretable. Among interpretable scans, interobserver agreement (Kendall statistic) in assessing wall motion was 0.73 for MIBI and 0.66 for thallium (P = .01). For assessing wall thickening, the Kendall statistic was 0.73 for MIBI and 0.69 for thallium (P = .05). Correlation (r) of LVEFs was 0.91, SEE = 6.4.
CONCLUSIONS: We conclude that gated thallium SPECT is inferior to MIBI because of much poorer image quality and somewhat poorer interobserver agreement among experienced physicians. However, LVEF can be determined reliably from gated thallium SPECT.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385183     DOI: 10.1016/s1071-3581(99)90040-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  7 in total

1.  Assessment of systolic thickening with thallium-201 ECG-gated single-photon emission computed tomography: a parameter for local left ventricular function.

Authors:  T Mochizuki; K Murase; Y Fujiwara; S Tanada; K Hamamoto; W N Tauxe
Journal:  J Nucl Med       Date:  1991-08       Impact factor: 10.057

2.  Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms.

Authors:  L L Johnson; S A Verdesca; W Y Aude; R C Xavier; L T Nott; M W Campanella; G Germano
Journal:  J Am Coll Cardiol       Date:  1997-12       Impact factor: 24.094

3.  Quantitative LVEF and qualitative regional function from gated thallium-201 perfusion SPECT.

Authors:  G Germano; J Erel; H Kiat; P B Kavanagh; D S Berman
Journal:  J Nucl Med       Date:  1997-05       Impact factor: 10.057

4.  Left ventricular ejection fraction assessed from gated technetium-99m-sestamibi SPECT.

Authors:  E G DePuey; K Nichols; C Dobrinsky
Journal:  J Nucl Med       Date:  1993-11       Impact factor: 10.057

5.  ECG-gated thallium-201 myocardial SPECT in patients with old myocardial infarction compared with ECG-gated blood pool SPECT.

Authors:  T Mochizuki; K Murase; Y Fujiwara; T Itoh; M Miyagawa; S Tanada; A Iio; K Hamamoto; W N Tauxe
Journal:  Ann Nucl Med       Date:  1991-07       Impact factor: 2.668

6.  Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact.

Authors:  E G DePuey; A Rozanski
Journal:  J Nucl Med       Date:  1995-06       Impact factor: 10.057

7.  Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy.

Authors:  T Chua; H Kiat; G Germano; G Maurer; K van Train; J Friedman; D Berman
Journal:  J Am Coll Cardiol       Date:  1994-04       Impact factor: 24.094

  7 in total
  16 in total

1.  Sources of variability of gated myocardial perfusion SPECT quantitative parameters.

Authors:  E Gordon DePuey
Journal:  J Nucl Cardiol       Date:  2015-09-04       Impact factor: 5.952

2.  EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology.

Authors:  B Hesse; K Tägil; A Cuocolo; C Anagnostopoulos; M Bardiés; J Bax; F Bengel; E Busemann Sokole; G Davies; M Dondi; L Edenbrandt; P Franken; A Kjaer; J Knuuti; M Lassmann; M Ljungberg; C Marcassa; P Y Marie; F McKiddie; M O'Connor; E Prvulovich; R Underwood; B van Eck-Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

3.  Myocardial perfusion and function single photon emission computed tomography.

Authors:  Christopher L Hansen; Richard A Goldstein; Daniel S Berman; Keith B Churchwell; C David Cooke; James R Corbett; S James Cullom; Seth T Dahlberg; James R Galt; Ravi K Garg; Gary V Heller; Mark C Hyun; Lynne L Johnson; April Mann; Benjamin D McCallister; Raymond Taillefer; R Parker Ward; John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

4.  Improved diagnosis and prognosis using Decisions Informed by Combining Entities (DICE): results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Mark Doyle; Gerald M Pohost; C Noel Bairey Merz; Leslee J Shaw; George Sopko; William J Rogers; Barry L Sharaf; Carl J Pepine; Diane A Vido-Thompson; Geetha Rayarao; Lindsey Tauxe; Sheryl F Kelsey; Douglas Mc Nair; Robert W Biederman
Journal:  Cardiovasc Diagn Ther       Date:  2013-12

5.  Comparison of 8-frame and 16-frame thallium-201 gated myocardial perfusion SPECT for determining left ventricular systolic and diastolic parameters.

Authors:  Satoshi Kurisu; Yoji Sumimoto; Hiroki Ikenaga; Noriaki Watanabe; Ken Ishibashi; Yoshihiro Dohi; Yukihiro Fukuda; Yasuki Kihara
Journal:  Heart Vessels       Date:  2016-12-17       Impact factor: 2.037

6.  Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study.

Authors:  Mark Doyle; Nicole Weinberg; Gerald M Pohost; C Noel Bairey Merz; Leslee J Shaw; George Sopko; Anthon Fuisz; William J Rogers; Edward G Walsh; B Delia Johnson; Barry L Sharaf; Carl J Pepine; Sunil Mankad; Steven E Reis; Geetha Rayarao; Diane A Vido; Vera Bittner; Lindsey Tauxe; Marian B Olson; Sheryl F Kelsey; Robert Ww Biederman
Journal:  Cardiovasc Diagn Ther       Date:  2013-06

7.  Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE).

Authors:  Mark Doyle; Gerald M Pohost; C Noel Bairey Merz; Leslee J Shaw; George Sopko; William J Rogers; Barry L Sharaf; Carl J Pepine; Diane V Thompson; Geetha Rayarao; Lindsey Tauxe; Sheryl F Kelsey; Robert W W Biederman
Journal:  Cardiovasc Diagn Ther       Date:  2016-10

8.  Imaging technology for myocardial perfusion single-photon emission computed tomography 2018 in Japan.

Authors:  Takayuki Shibutani; Koichi Okuda; Hajime Ichikawa; Toyohiro Kato; Kenta Miwa; Hiroyuki Tsushima; Masahisa Onoguchi; Akio Nagaki
Journal:  Jpn J Radiol       Date:  2020-01-09       Impact factor: 2.374

9.  Reproducibility of Tl-201 and Tc-99m sestamibi gated myocardial perfusion SPECT measurement of myocardial function.

Authors:  I Y Hyun; J Kwan; K S Park; W H Lee
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

10.  Normal limits for left ventricular ejection fraction and volumes estimated with gated myocardial perfusion imaging in patients with normal exercise test results: influence of tracer, gender, and acquisition camera.

Authors:  A A Ababneh; R R Sciacca; B Kim; S R Bergmann
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.